Key Statistics
Market Cap$88.17M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.11
52W High$3.35
52W Low$1.03
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+11.26%
3 Month-30.00%
1 Year+61.54%
About
OKYO Pharma Limited, a preclinical biopharmaceutical company, is engaged in developing therapies for patients suffering from inflammatory eye diseases and eye pain in the UK. The company is headquartered in London, the United Kingdom.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze OKYO with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.